You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 5, 2025

POTASSIUM CHLORIDE 0.037% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Potassium Chloride 0.037% In Sodium Chloride 0.9% In Plastic Container, and what generic alternatives are available?

Potassium Chloride 0.037% In Sodium Chloride 0.9% In Plastic Container is a drug marketed by B Braun and is included in one NDA.

The generic ingredient in POTASSIUM CHLORIDE 0.037% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER is potassium chloride; sodium chloride. There are two hundred and forty drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the potassium chloride; sodium chloride profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for POTASSIUM CHLORIDE 0.037% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER?
  • What are the global sales for POTASSIUM CHLORIDE 0.037% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER?
  • What is Average Wholesale Price for POTASSIUM CHLORIDE 0.037% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER?
Summary for POTASSIUM CHLORIDE 0.037% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Drug patent expirations by year for POTASSIUM CHLORIDE 0.037% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Pharmacology for POTASSIUM CHLORIDE 0.037% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

US Patents and Regulatory Information for POTASSIUM CHLORIDE 0.037% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Exclusivity Expiration
B Braun POTASSIUM CHLORIDE 0.037% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER potassium chloride; sodium chloride INJECTABLE;INJECTION 019708-001 Sep 29, 1989 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Exclusivity Expiration
Showing 1 to 1 of 1 entries

POTASSIUM CHLORIDE 0.037% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER Market Analysis and Financial Projection

Potassium Chloride in Sodium Chloride: Market Dynamics and Financial Trajectory

Overview of Potassium Chloride

Potassium chloride (KCl), often referred to as potassium salt, is a vital compound consisting of chlorine and potassium. It is widely used across various industries, including agriculture, food processing, pharmaceuticals, and water treatment. Here, we will focus on its application in medical solutions, specifically Potassium Chloride in Sodium Chloride injections.

Market Size and Growth

The global potassium chloride market, which includes its medical applications, is projected to grow significantly. As of 2023, the market is valued at approximately US$ 13,084.0 million and is expected to reach US$ 18,102.7 million by 2033, growing at a CAGR of 3.3% during this period[1].

Key End-Use Industries

Agriculture

Potassium chloride is a crucial fertilizer, known as potash, which promotes healthy crop growth and increases yields. The increasing demand for food due to a growing global population drives the demand for potassium chloride in agriculture.

Food Processing

In the food industry, potassium chloride is used as a salt substitute, particularly for individuals concerned about their sodium intake. This application contributes to the steady demand for potassium chloride.

Pharmaceuticals

In the medical sector, potassium chloride is used in various formulations, including intravenous solutions. These solutions are essential for fluid and electrolyte replenishment, making them a critical component in healthcare.

Water Treatment

Potassium chloride is also used as a coagulant in water treatment to remove impurities and improve water quality.

Regional Market Dynamics

United States

The United States is a significant market for potassium chloride, holding an 86.1% share in the North American industry. The demand is driven by its use as a fertilizer in agriculture and its applications in pharmaceuticals, water treatment, and food processing. Advancements in technology and the availability of low-cost natural resources further support market growth in the U.S.[1].

China

China is another major player, with the government focusing on industrial expansion in sectors such as water treatment, food processing, and agriculture. This expansion is expected to drive the demand for potassium chloride, making China a dominant market in Asia between 2023 and 2033[1].

Market Competition and Consolidation

The potassium chloride market is currently fairly consolidated, with top players holding a significant share. However, there is an expectation of fragmentation as emerging players capitalize on market opportunities. Key players are anticipated to engage in production facility expansions and acquisitions to maintain their market position[1].

Clinical Use and Safety of Potassium Chloride in Sodium Chloride Injections

Clinical Pharmacology

Potassium Chloride in Sodium Chloride Injection, USP, is a sterile, nonpyrogenic solution used for fluid and electrolyte replenishment. It can induce diuresis depending on the patient's clinical condition[4].

Safety and Precautions

The administration of potassium chloride in intravenous solutions can lead to several adverse reactions, including electrolyte disturbances, fluid overload, and cardiac disorders. It is crucial to monitor fluid balance, electrolyte concentrations, and acid-base balance during treatment. Geriatric patients are at a higher risk of developing electrolyte imbalances due to impaired renal function[2][4].

Adverse Reactions

Common adverse reactions include hyperkalemia, hyponatremia, hypernatremia, and fluid overload. Severe reactions can manifest as cardiac arrest, seizures, and cerebral edema. The risk of these reactions is higher in patients with diminished renal function or those treated with drugs that increase the risk of hyperkalemia[4][5].

Financial Trajectory

The financial trajectory of the potassium chloride market, including its medical applications, is positive. Here are some key financial insights:

  • Market Value: The global potassium chloride market is expected to grow from US$ 13,084.0 million in 2023 to US$ 18,102.7 million by 2033[1].
  • CAGR: The market is projected to grow at a CAGR of 3.3% between 2023 and 2033[1].
  • Regional Contribution: The United States and China are expected to remain prominent countries, accounting for over 40% of the market share. The U.S. holds an 86.1% share in the North American industry, while China is expected to be the dominant market in Asia[1].

Key Takeaways

  • The global potassium chloride market is growing steadily, driven by demand from agriculture, food processing, pharmaceuticals, and water treatment.
  • The United States and China are key markets, with significant production and consumption of potassium chloride.
  • The use of potassium chloride in medical solutions, such as intravenous injections, is critical for fluid and electrolyte replenishment but requires careful monitoring due to potential adverse reactions.
  • The market is expected to expand through 2033, with a projected CAGR of 3.3%.

FAQs

Q: What are the primary uses of potassium chloride?

A: Potassium chloride is used as a fertilizer in agriculture, a salt substitute in food processing, a coagulant in water treatment, and as an electrolyte replenisher in medical solutions.

Q: What is the projected market value of potassium chloride by 2033?

A: The global potassium chloride market is expected to reach US$ 18,102.7 million by 2033[1].

Q: Which regions are expected to dominate the potassium chloride market?

A: The United States and China are expected to remain prominent countries, accounting for over 40% of the market share[1].

Q: What are the potential adverse reactions of potassium chloride in intravenous solutions?

A: Potential adverse reactions include electrolyte disturbances, fluid overload, cardiac disorders, and severe reactions such as cardiac arrest and cerebral edema[4][5].

Q: Why is monitoring important during the administration of potassium chloride in intravenous solutions?

A: Monitoring is crucial to manage fluid balance, electrolyte concentrations, and acid-base balance, especially in patients with diminished renal function or those treated with drugs that increase the risk of hyperkalemia[2][4].

Sources

  1. Future Market Insights, "Potassium Chloride Market Size, Growth, Trend & Share | 2033"
  2. Baxter, "Potassium Chloride in 0.45% Sodium Chloride Injection, USP"
  3. DailyMed, "Potassium Chloride in Sodium Chloride Injection, USP in Plastic Container"
  4. Drugs.com, "Potassium Chloride in Sodium Chloride: Package Insert"
  5. FDA, "Highly Concentrated - Potassium Chloride Injection"

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.